ARK Invest Reshuffles Biotech, Sells Coinbase & Ginkgo by Lilu Anderson 25.06.2024 Cathie Wood's ARK shifts focus, selling Ginkgo and Coinbase, while investing in 10X Genomics and Roku in a biotech-centered portfolio ...
U.S. Crackdown on Chinese Biotech Could Harm Patients by Lilu Anderson 22.06.2024 America's crackdown on Chinese biotech could lead to drug shortages and higher costs, impacting patients without delivering promised security benefits.
Fortress Biotech Sees Upgrades Amid Investor Shifts by Lilu Anderson 20.06.2024 "Fortress Biotech (FBIO) upgraded to 'Hold' by StockNews.com amid 5.8% decline; analysts offer mixed ratings as hedge funds increase stakes."
Day One Biopharma Expands to ADCs with $55M Drug Acquisition by Lilu Anderson 19.06.2024 "Day One Biopharmaceuticals enhances pipeline, acquiring global rights to promising PTK7-targeting cancer drug DAY301, begins trial soon."
EU’s First Cultivated Meat Tasting: A Positive Step Forward by Lilu Anderson 19.04.2024 Meatable, the cultivated meat market, plans to launch pork products in Singapore next year after a successful tasting event in ...
Neuralink Brain Chip Implant: First Human Revealed by Lilu Anderson 06.04.2024 The first human to receive a Neuralink brain chip has been revealed as Noland Arbaugh, leading people to question if ...
U.S. IPO Weekly Recap: Biotech Leads Short Week by Mark Eisenberg 30.03.2024 Phase 1 biotech Boundless Bio raised $100 million at a $396 million market cap. Two IPOs are scheduled for the ...
Viva Biotech Holdings FY 2023 Earnings: CN¥0.06 Loss Per Share by Mark Eisenberg 30.03.2024 Viva Biotech Holdings reported a 9.4% decrease in revenue and narrowed its net loss by 78% in FY 2023. Loss ...
BNR Stock Earnings: Burning Rock Biotech Q4 2023 Results by Mark Eisenberg 29.03.2024 Burning Rock Biotech reported an earnings per share of -22 cents and revenue of $17.05 million. For concerns, contact [email protected].
Kingswood Wealth Advisors Sells 465 Shares of SPDR S&P Biotech ETF by Terry Bingman 28.03.2024 Resources Management Corp CT ADV increased its position in SPDR S&P Biotech ETF by 1,715.8% in Q2. Fortis Capital Advisors ...